The serum levels of the proangiogenic markers (MMP-2, MMP-9, VEGF, FGF2) and HIF-1 alpha (a marker of hypoxia) were higher in cSCC patients compared to AK patients and controls. The gene discussed is VEGFA; the disease is skin squamous cell carcinoma.